|
Volumn 16, Issue 1, 2001, Pages 29-34
|
Intraperitoneal administration of recombinant human growth hormone in children with end-stage renal disease
a b b b a a |
Author keywords
Dialysis; Growth; Peritoneal; Recombinant human growth hormone
|
Indexed keywords
RECOMBINANT GROWTH HORMONE;
ADOLESCENT;
ARTICLE;
BODY HEIGHT;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG TOLERABILITY;
EVALUATION;
GROWTH DISORDER;
GROWTH HORMONE BLOOD LEVEL;
GROWTH RATE;
HORMONE RESISTANCE;
HUMAN;
INFECTION RATE;
KIDNEY FAILURE;
PERITONEAL DIALYSIS;
PERITONITIS;
PRIORITY JOURNAL;
SHORT STATURE;
ADOLESCENT;
CHILD;
CHILD DEVELOPMENT;
CHILD, PRESCHOOL;
FEMALE;
HUMAN GROWTH HORMONE;
HUMANS;
INJECTIONS, INTRAPERITONEAL;
KIDNEY FAILURE, CHRONIC;
MALE;
NUTRITIONAL STATUS;
PERITONEAL DIALYSIS;
RECOMBINANT PROTEINS;
SAFETY;
|
EID: 0035134158
PISSN: 0931041X
EISSN: None
Source Type: Journal
DOI: 10.1007/s004670000430 Document Type: Article |
Times cited : (4)
|
References (31)
|